Form CMS (5/2017) Page 1

Similar documents
DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES

Hospice and End of Life Care and Services Critical Element Pathway

Use this pathway if there are activity concerns for a resident to determine if the facility is meeting the resident s activity needs.

Activities of Daily Living (ADL) Critical Element Pathway

Tube Feeding Status Critical Element Pathway

Observations: Observe the resident at a minimum of two meals:

Stage 2 General Critical Element Pathway Facility Name: Facility ID: Date: Surveyor Name:

Observations for all areas: What type of supervision is provided to the resident and by whom? How are care-planned interventions implemented?

Behavioral and Emotional Status Critical Element Pathway

The CMS State Operations Manual Overview and Changes

Pain: Facility Assessment Checklists

MDS Essentials. MDS Essentials: Content. Faculty Disclosures 5/22/2017. Educational Activity Completion

Pain: Facility Assessment Checklists

Psychotropic Drug Use To Medicate or Not to Medicate?

Interim Final Interpretive Guidelines Version 1.1

Pharmacy Services. Division of Nursing Homes

Medication Related Changes Phase 1&2

Federal Requirements of Participation for Nursing Homes Summary of Key Changes in the Final Rule Issued September 2016 Phase 2

CMS s RAI Version 3.0 Manual October 2016

OIG Risk Areas: Comprehensive Care Plans, Restorative/Personal Care Services & Medication Management

Developing and Action Plan: Person Centered Dementia Care and Psychotropic Medications

3/6/2017. CMS nursing home requirements have not been comprehensively updated since 1991 despite significant changes in the industry.

Reviewing regulatory requirements for top ten federal Nursing Home Tags issued in Minnesota. Eva Loch, MDH Nursing Evaluator

COMMONWEALTH OF KENTUCKY OFFICE OF INSPECTOR GENERAL AND MYERS AND STAUFFER LC PRESENT MDS CODING AND INTERPRETATION ANSWER SLIDES

RALF Behavior Management Rules IDAPA

does staff intervene; used? If not, describe.

MDS 3.0/RUG IV OVERVIEW

FAMU OFFICE OF HUMAN RESOURCES FLORIDA AGRICULTURAL & MECHANICAL UNIVERSITY

What s Happening in the Nursing Home? Cherry Meier, RN, MSN, NHA Vice President of Public Affairs

Instructions : To be completed by Practitioner or Physician only. PLEASE PRINT CLEARY 1. Employee s Name 2. Patient s Name (if other than employee)

Tag Description Page. F607 Policies to Prohibit and Prevent Abuse, Neglect, Exploitation 125. F622 Transfer & Discharge 155

Maryland. Prescribing and Dispensing Profile. Research current through November 2015.

MDS 3.0 and PASRR. 10/12/2010 Webinar for NAPP members. Dan Timmel CMS PASRR Technical Assistance Center. Slides prepared by Breck Douglas (9/10)

Hospice Care in the Nursing Home: The New Interpretive Guidelines for NF Surveyors

The Consultant Pharmacist: The IDT Approach to Pharmacotherapy Care and Compliance with the CMS Final Rule

MEDICATION MONITORING AND MANAGEMENT Procedures

Practice Tools for Safe Drug Therapy

DEMONSTRATED NEED FOR SKILLED CARE FOR MEDICARE PATIENTS: SKILLED NURSING SERVICES

Proposed Standards Revisions Related to Pain Assessment and Management

PERFORMANCE MEASURE DATE / RESULTS / ANALYSIS FOLLOW-UP / ACTION PLAN

Based on the comprehensive assessment of a resident, the facility must ensure that:

Contents. Introduction 3. Required knowledge and skills 4. Section One: Knowledge and skills for all nurses and care staff 6

Organization: Solution Title: Program/Project Description, including Goals: What is this project? Why is this project important?

The Changing Role of Physicians in LTCF

CASE MANAGEMENT POLICY

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Community Health Network of San Francisco Committee on Interdisciplinary Practice

Safe Transitions Best Practice Measures for

9/8/2017. Making the Connection: Linking the Facility Assessment and QAPI Plan. Cindy Mason VP Provider Services. Final Rule. Providigm, LLC,

Critical Thinking Steps

Pre-Admission Screening and Resident Review

Schedule 3. Services Schedule. Occupational Therapy

Notes from CMS Final Rule Document Pertinent to Culture Change and Person-directed Care

Highlights of the New LTCSP and Regulations

Get Ready for Phase 1 of the New Requirements of Participation

MEDICAL CERTIFICATION FROM HEALTH CARE PROVIDER FMLA LEAVE (to be submitted within fifteen (15) days of employee requesting FMLA leave)

NHS Fife. Patient Group Direction for Named Community Pharmacists to Supply

What do we promise people who are dying and those around them when we tell them about hospice care?

5. returning the medication container to proper secured storage; and

Behavioral Health Services. Division of Nursing Homes

Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment

Wyoming State Survey Agency

Caring in the Carolinas 11/5/2016

Monitoring Medication Storage & Administration

Employee s Name: EIN: FMLA Case # (if known):

RULE RESPONSIBILITIES OF A PHYSICIAN WHO ENGAGES IN DRUG THERAPY MANAGEMENT WITH A COLORADO LICENSED PHARMACIST

Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists

VNAA Blueprint for Excellence PATHWAY TO BEST PRACTICES

Medication Management: Therapy Scope Versus Comfort Level

MINNESOTA. Downloaded January 2011

Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02

READMISSION ROOT CAUSE ANALYSIS REPORT

ADMISSION CONSENTS. 1. Yes No Automobile Medical or No Fault insurance due to an accident?

NJ Level of Care and Assessment Process

NALC Form 1 - Family and Medical Leave Act of 1993 Employee Should Deliver Completed Form to Postal Service Supervisor, and Keep a Copy

Prepared Jointly by the American Society of Health-System Pharmacists and the Academy of Managed Care Pharmacy

Neglect Critical Element Pathway

CERTIFICATION OF HEALTH CARE PROVIDER

CLINICAL CRITERIA FOR UM DECISIONS Skilled Nursing Facilities

Safe Medication Assistance and Administration Policy

The Updated CMS Nursing Facility Regulations

Proposed Accreditation Requirements Related to the Care of Patients or Residents with Dementia

Test Content Outline Effective Date: February 6, Gerontological Nursing Board Certification Examination

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

Hey Recruit? You Ready for This?

October 2011 Quarterly CMS OCCB Q&As

Developmental Disabilities Supports Division (DDSD) Supersedes: New Policy. Policy Title: Medication Assessment and Delivery Policy

CMS Proposed Rule. The IMPACT Act. 3 Overhaul Discharge Planning Processes to Comply With New CoPs. Arlene Maxim VP of Program Development, QIRT

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. Discharge Planning

Policy Review Sheet. Review Date: 14/10/16 Policy Last Amended: 19/10/17. Next planned review in 12 months, or sooner as required.

HOW WE GOT HERE 1935: Social Security Act Private nursing homes

Restorative Nursing: The NHA s Role and Organizational Outcomes

Florida A&M University College of Pharmacy & Pharmaceutical Sciences

OASIS-B1 and OASIS-C Items Unchanged, Items Modified, Items Dropped, and New Items Added.

DEFINITIONS (c)(1) Discharge Planning : Home Health Agency (HHA) : Inpatient Rehabilitation Facility (IRF) : Local Contact Agency :

Attachment A - Comparison of OASIS-C (Current Version) to OASIS-C1 (Proposed Data Collection)

Interpretive Guidelines (b)(2) Interpretive Guidelines (b)(3)

MDS 3.0: What Leadership Needs to Know

Standards of Care Standards of Professional Performance

Transcription:

Use this pathway for a resident who has pain symptoms or can reasonably be expected to experience pain (i.e., during therapy) to determine whether the facility has provided and the resident has received care and services to address and manage the resident s pain in order to support his or her highest practicable level of physical, mental, and psychosocial well-being, in accordance with the comprehensive assessment and care plan, current professional standards of practice, and the resident s goals and preferences. Review the Following in Advance to Guide Observations and Interviews: Review the most current comprehensive and most recent quarterly (if the comprehensive isn t the most recent) MDS/CAAs for Sections C Cognitive Patterns, G Functional Status, J Health Conditions, K Swallowing/Nutritional Status, L Oral/Dental Status, N Medications, and O Special Treatment/Proc/Prog - dialysis (O100J) or hospice (O100K). Physician s orders (e.g., pain management interventions, PRN or routine pain medications, type of pain medications [opioid, non-steroidal antiinflammatory], and route [injectable, oral, topical]). Pertinent diagnoses. Care plan (e.g., measurable goals for pain management, current pain management interventions, pharmacological and non-pharmacological interventions, timeframes, and approaches for monitoring the status of the resident s pain, including the effectiveness of the interventions). Observations: Does the resident exhibit signs or symptoms of pain, verbalize the presence of pain, or request interventions for pain? Does the pain appear to affect the resident s function or ability to participate in routine care or activities? If so, describe. For non-verbal or cognitively-impaired residents who cannot verbalize their pain, how does staff assess for the presence of pain and effectiveness of interventions for pain? If there is evidence of pain, how does staff assess the situation, identify, and implement interventions to try to prevent or address the pain, and evaluate the status of the resident s pain after If care and services are being provided that reasonably could be anticipated to cause pain, such as therapy, how does staff identify and address these issues, to the extent possible? How does staff respond if there is a report from the resident, family, or staff that the resident is experiencing pain? If there are pain management interventions for the resident, how does staff ensure they are implemented as ordered or care planned? What potential adverse consequences associated with treatment for pain (e.g., medications) does the resident have? How does staff respond if the interventions implemented did not reduce the pain consistent with the goals for pain management? How long does the resident wait to receive PRN pain medication after requesting it? Form CMS 20076 (5/2017) Page 1

Resident, Resident Representative, or Family Interview: How does the facility involve you in the development of the care plan and defining the approaches and goals? How does the facility ensure the interventions reflect your/the resident s choices and preferences? How are you involved in developing and revising pain management strategies and revisions to the care plan if the interventions did not work? Describe the characteristics of the pain, including the intensity, pain rating, type (e.g., burning, stabbing, tingling, aching), patterns of pain (e.g., constant or intermittent), location, radiation of pain, and frequency, timing, and duration of pain. Nursing Aide Interview: Does the resident experience any pain during assistance with activities of daily living? If so, what do you do? Does the resident have any complaints, or exhibit any signs or symptoms of pain? What factors may precipitate or alleviate the pain? How have you typically expressed pain and responded to various interventions in the past? Who have you told about the pain/discomfort? How has staff responded? How long does it take for you to receive pain medication when you have asked for it? What treatment options (pharmacological and/or nonpharmacological) were discussed and attempted? How effective have the interventions been? Have you refused any interventions (i.e., certain types of medications or nonpharmacological ways to reduce pain without medication)? If so, was there a discussion of the potential impact on you, and what alternatives or other approaches were offered? To whom do you report the resident s complaints and signs or symptoms? Do you know what interventions are on the resident s care plan for pain/discomfort management (e.g., allowing a period of time for a pain medication to take effect before bathing or dressing)? Do you implement any interventions to relieve the resident s pain? Nurse, DON, Hospice Nurse, Attending Practitioner, Pharmacist, Medical Director Interviews: Is there a tool that is used to assess residents with pain? Is the same tool used for everyone? How is the resident assessed for pain? How and when do staff try to identify circumstances in which pain can be anticipated? For residents receiving pain medication (including PRN and adjuvant medications), how, when, and by whom are the results of medications evaluated (dose, frequency of PRN use, schedule of How do you monitor for the emergence or presence of adverse events related to opioid medications or the consequences of For residents with significant, or difficult to manage pain: How were the interventions developed? What was the basis for selecting them? How do you guide and oversee the selection of pain management Form CMS 20076 (5/2017) Page 2

routine medications, and effectiveness)? How often is the resident s pain regimen reviewed, and what triggers a review? What is done if pain persists or recurs despite treatment? What is the basis for decisions to maintain or modify approaches? How does staff communicate with the prescriber about the resident s pain status, current measures to manage pain, and the possible need to modify the current pain management Record Review: Review information such as MARs, controlled medication records/count sheets, multidisciplinary progress notes, and any specific assessments regarding pain that may have been completed. Determine whether the information accurately and comprehensively reflects the resident s condition, and extent to which pain is managed. What indicators and characteristics of the resident s pain, including causes and contributing factors related to pain, have been identified, and addressed in the care plan? Did the facility identify the resident s history of pain and related If not, describe. What was the resident s response to interventions, including efficacy and adverse consequences and any modification of interventions as indicated? Do pain management interventions have a documented rationale and is it consistent with current standards of practice? What clinically significant medication-related adverse consequences, such as a change in mental status/delirium, falling, constipation, anorexia, or drowsiness, has the resident experienced? What was the plan to try to minimize those adverse consequences? Are you aware of any situation where the resident had pain, but interventions were not utilized? If so, why did this occur? Was there a rationale? Have any of this resident s interventions been ineffective, or caused adverse consequences? If so, when and with whom was this discussed? For a resident who is receiving care under a hospice benefit, how does the hospice and the facility coordinate their approaches and communicate about the resident s needs and monitor the outcomes (both effectiveness and adverse consequences)? Is the care plan comprehensive? Does it reflect the resident s needs and preferences? How did the resident respond to care-planned If interventions weren t effective, the pain was not resolved, or the resident experienced a change of condition, was the care plan revised? Was there a "significant change" in the resident's condition (i.e., will not resolve itself without intervention by staff or by implementing standard disease-related clinical interventions; impacts more than one area of health; requires IDT review or revision of the care plan)? If so, was a significant change comprehensive assessment conducted within 14 days? If the resident has elected a hospice benefit, is there evidence that the resident s care is coordinated between the nursing home and the hospice? This includes aspects of pain management, such as: o Choice of palliative interventions; o Responsibility for assessing pain and providing interventions; and o Responsibility for monitoring symptoms and adverse consequences of interventions and for modifying interventions as needed. Form CMS 20076 (5/2017) Page 3

Critical Element Decisions: 1) Did the facility identify, treat, monitor, and manage the resident s pain to the extent possible in accordance with the comprehensive assessment and care plan, current professional standards of practice, and the resident s goals and preferences? If No, cite F697 2) For newly admitted residents and if applicable based on the concern under investigation, did the facility develop and implement a baseline care plan within 48 hours of admission that included the minimum healthcare information necessary to properly care for the immediate needs of the resident? Did the resident and resident representative receive a written summary of the baseline care plan that he/she was able to understand? If No, cite F655 NA, the resident did not have an admission since the previous survey OR the care or service was not necessary to be included in a baseline care plan. 3) If the condition or risks were present at the time of the required comprehensive assessment, did the facility comprehensively assess the resident s physical, mental, and psychosocial needs to identify the risks and/or to determine underlying causes, to the extent possible, and the impact upon the resident s function, mood, and cognition? If No, cite F636 NA, condition/risks were identified after completion of the required comprehensive assessment and did not meet the criteria for a significant change MDS OR the resident was recently admitted and the comprehensive assessment was not yet required. 4) If there was a significant change in the resident s status, did the facility complete a significant change assessment within 14 days of determining the status change was significant? If No, cite F637 NA, the initial comprehensive assessment had not yet been completed; therefore, a significant change in status assessment is not required OR the resident did not have a significant change in status. 5) Did staff who have the skills and qualifications to assess relevant care areas and who are knowledgeable about the resident s status, needs, strengths and areas of decline, accurately complete the resident assessment (i.e., comprehensive, quarterly, significant change in status)? If No, cite F641 6) Did the facility develop and implement a comprehensive person-centered care plan that includes measureable objectives and timeframes to meet a resident s medical, nursing, mental, and psychosocial needs and includes the resident s goals, desired outcomes, and preferences? If No, cite F656 NA, the comprehensive assessment was not completed. Form CMS 20076 (5/2017) Page 4

7) Did the facility reassess the effectiveness of the interventions and review and revise the resident s care plan (with input from the resident or resident representative, to the extent possible), if necessary to meet the resident s needs? If No, cite F657 NA, the comprehensive assessment was not completed OR the care plan was not developed OR the care plan did not have to be revised. Other Tags, Care Areas (CA) and Tasks (Task) to Consider: Advance Directives (CA), Choices (CA), Notification of Change F580, Accommodation of Needs (Environment Task), Professional Standards F658, Related Quality of Care (e.g., Dental, Hospice, Pressure Ulcers, Positioning/Mobility/ROM), Unnecessary Medications (CA), Physician Supervision F710, Pharmacy Services F755, Medical Director F841, Resident Records F842. Form CMS 20076 (5/2017) Page 5